Loading...

Course Description

Joint disease is the leading cause of equine wastage. Horses suffer from bone and joint pain secondary to many causes, including conformation, overuse and injury. Here, we will discuss options for management of both acute and chronic joint disease, including analgesics, disease-modifying osteoarthritis drugs (DMOADs) and symptom-modifying osteoarthritis drugs (SMOADs). Corticosteroids, non-steroidal anti-inflammatories and hyaluronic acid have been mainstays of equine joint therapy for decades and continue to play an important role in management of joint disease. In addition, new and emerging therapeutics, including orthobiologics, bisphosphonates and other intra-articular compounds will be covered. Treatment options for low- and high-motion joints will be compared and contrasted, including both pharmacologic and non-pharmacologic therapies. Chemical and surgical options for facilitated ankylosis or arthrodesis of low-motion joints affected by advanced osteoarthritis will be discussed. Case studies will be used to stimulate discussion, compare and contrast potential therapeutic approaches, and demonstrate indications and contraindications for specific treatments.

Benefits to the Learner

  • Review the pathophysiology of joint disease in low- and high-motion joints
  • Assess pharmacologic treatment options for management of acute and chronic joint disease
  • Identify indications and contraindications for facilitated ankylosis or arthrodesis of joints affected by advanced osteoarthritis

Accrediting Associations

Loading...
Thank you for your interest in this course. Unfortunately, the course you have selected is currently not open for enrollment. Please complete a Course Inquiry so that we may promptly notify you when enrollment opens.
Required fields are indicated by .